PACB +559%: a post-crash base breakout in genomics, August 2020
On 7 August 2020, Pacific Biosciences opened at $4.26, two cents above its July high, and closed at $4.73, up 15.9% on volume 5.9 times its 20-day average. Seven months…
Comments Off on PACB +559%: a post-crash base breakout in genomics, August 2020
November 15, 2026
